Boston IVF, LLP, a leading fertility clinic headquartered in the United States, has been at the forefront of reproductive medicine since its establishment in 1986. With a strong presence in major operational regions across New England, the clinic offers a comprehensive range of services, including in vitro fertilisation (IVF), egg freezing, and donor programmes. Renowned for its innovative approaches and high success rates, Boston IVF stands out in the industry with its commitment to personalised patient care and advanced reproductive technologies. The clinic has achieved numerous accolades, solidifying its position as a trusted provider in the fertility sector. With a focus on research and education, Boston IVF continues to set benchmarks in reproductive health, making it a pivotal player in the journey towards parenthood for many individuals and couples.
How does Boston IVF, LLP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Boston IVF, LLP's score of 25 is higher than 53% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Boston IVF, LLP, headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The organisation is a current subsidiary of IVIRMA Global SL, which may influence its climate-related initiatives and performance metrics. Despite the lack of direct emissions data, Boston IVF, LLP is part of a broader corporate family that may have established climate commitments. However, there are no documented reduction targets or climate pledges available for Boston IVF, LLP at this time. This suggests that while the organisation may be aware of the importance of sustainability, specific actionable goals or achievements in carbon reduction have not been publicly disclosed. As a current subsidiary, Boston IVF, LLP may benefit from the climate strategies and initiatives implemented by IVIRMA Global SL, but details on these initiatives are not specified. The absence of emissions data and reduction targets highlights a potential area for improvement in transparency and commitment to climate action within the organisation.
Access structured emissions data, company-specific emission factors, and source documents
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 876.41 | 000.00 | 000,000 | 000,000 | 000,000 | 000,000 | 0,000,000 |
| Scope 2 | 2,882,780 | 0,000,000 | - | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | - | - | - | 000,000 | 000,000 | 00,000,000 | - |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Boston IVF, LLP has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
